
Intrasinus thrombolysis in cerebral venous sinus thrombosis: Experience from a university hospital, India
Author(s) -
Neeharika L Mathukumalli,
Ram Murti Susarla,
Mridula R Kandadai,
Suryaprabha Turaga,
Jabeen A Shaik,
Suvarna Alladi,
Meena A Kanikannan,
Rupam Borgohain,
Subhash Kaul
Publication year - 2016
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/0972-2327.186785
Subject(s) - medicine , cerebral venous sinus thrombosis , thrombolysis , modified rankin scale , heparin , urokinase , papilledema , surgery , thrombosis , fibrinolytic agent , warfarin , argatroban , venous thrombosis , anesthesia , tissue plasminogen activator , ischemia , ischemic stroke , myocardial infarction , platelet , thrombin , atrial fibrillation
Intrasinus thrombolysis (IST) is believed to improve outcome in patients of cerebral venous sinus thrombosis (CVST) unresponsive to heparin.